AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32171028 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive medication reviews (CMRs) post-discharge
Number of subjects: 2637
Study 32171028 — intervention group
Group type: COMPARATOR
Intervention: Control group (no comprehensive medication reviews)
Number of subjects: 2637
Study 32171028 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (CMRs)
Number of subjects: 2637
Study 35850961 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-30 mg oral sustained-release morphine daily for 4 weeks
Number of subjects: 45
Study 33934542 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical phenogroups identified through unsupervised machine learning
Number of subjects: 1693
Study 33934542 — intervention group
Group type: COMPARATOR
Intervention: LVEF-based classifications
Number of subjects: 1693
Study 34252106 — intervention group
Group type: EXPERIMENTAL
Intervention: wMel-infected Ae. aegypti mosquito deployments
Number of subjects: 373000
Study 32551828 — intervention group
Group type: EXPERIMENTAL
Intervention: PARO (individual, nonfacilitated, 30‐min sessions with the robotic seal PARO, 5 days per week for 6 weeks)
Number of subjects: 43
Study 32551828 — intervention group
Group type: COMPARATOR
Intervention: Usual-care group
Number of subjects: 43
Study 34237681 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplant (FMT)
Number of subjects: 6
Study 32146218 — intervention group
Group type: EXPERIMENTAL
Intervention: ACT-DL (n = 27)
Number of subjects: 55
Study 32146218 — intervention group
Group type: COMPARATOR
Intervention: Active control (n = 28)
Number of subjects: 55
Study 36429610 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT)
Number of subjects: 90
Study 36429610 — intervention group
Group type: EXPERIMENTAL
Intervention: Rigid Taping (RT)
Number of subjects: 90
Study 36429610 — intervention group
Group type: COMPARATOR
Intervention: Placebo Taping (C)
Number of subjects: 90
Study 33109480 — intervention group
Group type: EXPERIMENTAL
Intervention: Contemporary neuroscience approach (pain neuroscience education, stress management, cognition-targeted exercise therapy)
Number of subjects: 120
Study 33109480 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical therapy (biomedically focused education, graded and active exercise therapy)
Number of subjects: 120
Study 35478103 — intervention group
Group type: EXPERIMENTAL
Intervention: Group A: 50 μg misoprostol escalated to 100 μg and then to 200 μg every 4 h (max 600 μg daily)
Number of subjects: 124
Study 35478103 — intervention group
Group type: COMPARATOR
Intervention: Group B: 25 μg misoprostol followed by 100 μg every 4 h (max 300 μg daily)
Number of subjects: 124
Study 35478103 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (A and B)
Number of subjects: 124
Study 35968287 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture combined with auricular acupressure (A&AA)
Number of subjects: 360
Study 35968287 — intervention group
Group type: COMPARATOR
Intervention: Nicotine replacement therapy (NRT)
Number of subjects: 360
Study 33310170 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate loading group
Number of subjects: 88
Study 33310170 — intervention group
Group type: COMPARATOR
Intervention: Midnight fasting group (NPO group)
Number of subjects: 88
Study 36137672 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbreviated antiplatelet therapy (APT) regimen (DAPT stopped and 11 months single APT or 5 months in patients with oral anticoagulants)
Number of subjects: 4579
Study 36137672 — intervention group
Group type: EXPERIMENTAL
Intervention: Abbreviated antiplatelet therapy (APT) regimen
Number of subjects: 4579
Study 36137672 — intervention group
Group type: COMPARATOR
Intervention: Nonabbreviated antiplatelet therapy (APT) regimen (DAPT for minimum 3 months)
Number of subjects: 4579
Study 33422431 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote management through WeChat app
Number of subjects: 180
Study 33422431 — intervention group
Group type: COMPARATOR
Intervention: Traditional medical treatment (Control)
Number of subjects: 180
Study 34578811 — intervention group
Group type: EXPERIMENTAL
Intervention: Carbohydrate‐electrolytes (C + E)
Number of subjects: 19
Study 34578811 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g/L dipeptide (alanyl‐glutamine)‐electrolytes (AG + E)
Number of subjects: 19
Study 34578811 — intervention group
Group type: COMPARATOR
Intervention: Electrolytes only (E)
Number of subjects: 19
Study 34578811 — intervention group
Group type: COMPARATOR
Intervention: Water (W)
Number of subjects: 19
Study 34578811 — intervention group
Group type: EXPERIMENTAL
Intervention: AG + E and E
Number of subjects: 19
Study 33178291 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge assessment
Number of subjects: 373
Study 33178291 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitude assessment
Number of subjects: 373
Study 33178291 — intervention group
Group type: EXPERIMENTAL
Intervention: Infection prevention practice assessment
Number of subjects: 373
Study 33178291 — intervention group
Group type: EXPERIMENTAL
Intervention: Age category 20–29
Number of subjects: 373
Study 33178291 — intervention group
Group type: EXPERIMENTAL
Intervention: Female participants
Number of subjects: 373
Study 33178291 — intervention group
Group type: EXPERIMENTAL
Intervention: Single participants
Number of subjects: 373
Study 33178291 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater than ten years of working experience
Number of subjects: 373
Study 33178291 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive attitude
Number of subjects: 373
Study 33178291 — intervention group
Group type: EXPERIMENTAL
Intervention: Availability of water at working area
Number of subjects: 373
Study 35446628 — intervention group
Group type: EXPERIMENTAL
Intervention: ADT plus orteronel (300 mg oral twice daily)
Number of subjects: 1279
Study 35446628 — intervention group
Group type: COMPARATOR
Intervention: ADT with bicalutamide (50 mg oral once daily)
Number of subjects: 1279
Study 34702785 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month activity tracker intervention
Number of subjects: 231
Study 34702785 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 231
Study 32792359 — intervention group
Group type: EXPERIMENTAL
Intervention: High IO-score (24-gene RNA signature)
Number of subjects: 96
Study 33508375 — intervention group
Group type: EXPERIMENTAL
Intervention: Prone positioning
Number of subjects: 100
Study 33508375 — intervention group
Group type: COMPARATOR
Intervention: Supine positioning
Number of subjects: 100
Study 32249193 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostatic artery embolization (PAE)
Number of subjects: 45
Study 32249193 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection of the prostate (TURP)
Number of subjects: 45
Study 34738284 — intervention group
Group type: EXPERIMENTAL
Intervention: Dr. Erica (digital intervention with 3 months of multimedia messaging)
Number of subjects: 146
Study 34738284 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 146
Study 34738284 — intervention group
Group type: EXPERIMENTAL
Intervention: Dr. Erica (digital intervention)
Number of subjects: 146
Study 34126270 — intervention group
Group type: EXPERIMENTAL
Intervention: LAAO with same-day discharge and early cessation of antithrombotic therapy
Number of subjects: 229
Study 35691258 — intervention group
Group type: EXPERIMENTAL
Intervention: Pistacia atlantica subsp. Kurdica herbal capsule for 2 months
Number of subjects: 58
Study 35691258 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsule for 2 months
Number of subjects: 58
Study 33722477 — intervention group
Group type: EXPERIMENTAL
Intervention: Individualized follitropin delta dosing (AMH <15 pmol/l: 12 µg/day; AMH ≥15 pmol/l: 0.10–0.19 µg/kg/day; minimum 6 µg/day; maximum 12 µg/day)
Number of subjects: 347
Study 33722477 — intervention group
Group type: COMPARATOR
Intervention: Conventional follitropin beta dosing (150 IU/day for the first 5 days, with potential subsequent dose adjustments)
Number of subjects: 347
Study 33566703 — intervention group
Group type: EXPERIMENTAL
Intervention: HXLPE cup
Number of subjects: 58
Study 33566703 — intervention group
Group type: COMPARATOR
Intervention: ConvPE cup
Number of subjects: 58
Study 32505701 — intervention group
Group type: EXPERIMENTAL
Intervention: New Forest Parenting Programme
Number of subjects: 164
Study 32505701 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 164
Study 32796876 — intervention group
Group type: EXPERIMENTAL
Intervention: Smoking initiation (genetically predicted)
Number of subjects: 1232091
Study 33592303 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion (150 mg)
Number of subjects: 16
Study 33592303 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 32150141 — intervention group
Group type: EXPERIMENTAL
Intervention: FOOTFIT
Number of subjects: 24
Study 32150141 — intervention group
Group type: EXPERIMENTAL
Intervention: FOOTFIT+
Number of subjects: 24
Study 34958531 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostate-specific antigen (PSA) screening, kallikrein panel, and multiparametric MRI
Number of subjects: 399
Study 34958531 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional testing (kallikrein panel and MRI) after PSA
Number of subjects: 399
Study 33501854 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual Workshop (VW) group using multimedia software program
Number of subjects: 0
Study 33501854 — intervention group
Group type: COMPARATOR
Intervention: Actual Workshop (AW) group participating in a face-to-face workshop
Number of subjects: 0
Study 33501854 — intervention group
Group type: EXPERIMENTAL
Intervention: Both VW and AW groups
Number of subjects: 0
Study 33501854 — intervention group
Group type: EXPERIMENTAL
Intervention: VW teachers
Number of subjects: 0
Study 33501854 — intervention group
Group type: EXPERIMENTAL
Intervention: Both teacher groups
Number of subjects: 0
Study 33501854 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups of students
Number of subjects: 0
Study 32664064 — intervention group
Group type: EXPERIMENTAL
Intervention: Gwakhyangjeonggi-san (GJS)
Number of subjects: 58
Study 32664064 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 58
Study 33357672 — intervention group
Group type: EXPERIMENTAL
Intervention: 30°C 30%RH for 8 hours
Number of subjects: 240
Study 33357672 — intervention group
Group type: EXPERIMENTAL
Intervention: 30°C 80%RH for 8 hours
Number of subjects: 240
Study 33357672 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 hours exposure
Number of subjects: 240
Study 33357672 — intervention group
Group type: EXPERIMENTAL
Intervention: 30°C 30%RH
Number of subjects: 240
Study 33357672 — intervention group
Group type: EXPERIMENTAL
Intervention: -15°C uncontrolled RH
Number of subjects: 240
Study 33357672 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 hours exposure
Number of subjects: 240
Study 32483056 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 sessions per week of acupuncture (TSWA)
Number of subjects: 60
Study 32483056 — intervention group
Group type: COMPARATOR
Intervention: 1 session per week of acupuncture (OSWA)
Number of subjects: 60
Study 36198130 — intervention group
Group type: EXPERIMENTAL
Intervention: PlasmaJet Surgical Device
Number of subjects: 327
Study 36198130 — intervention group
Group type: COMPARATOR
Intervention: Conventional CRS
Number of subjects: 327
Study 33790400 — intervention group
Group type: EXPERIMENTAL
Intervention: Isometric exercises (maximum clenching for 10 seconds, repeated five times, twice daily for 4 weeks)
Number of subjects: 0
Study 33790400 — intervention group
Group type: COMPARATOR
Intervention: Control group (tapping teeth at arbitrary speed for 10 seconds, repeated five times, twice daily for 4 weeks)
Number of subjects: 0
Study 35673945 — intervention group
Group type: EXPERIMENTAL
Intervention: Scapular stabilization exercise (SSE) and postural correction exercises (PCE)
Number of subjects: 60
Study 35673945 — intervention group
Group type: COMPARATOR
Intervention: Postural correctional exercises (PCE)
Number of subjects: 60
Study 35673945 — intervention group
Group type: EXPERIMENTAL
Intervention: Scapular stabilization exercise (SSE)
Number of subjects: 60
Study 33491582 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol (100 mg)
Number of subjects: 29
Study 33491582 — intervention group
Group type: EXPERIMENTAL
Intervention: Paracetamol (1.5 g)
Number of subjects: 29
Study 33491582 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 29
Study 33491582 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol (100 mg) and Paracetamol (1.5 g)
Number of subjects: 29
Study 35277461 — intervention group
Group type: EXPERIMENTAL
Intervention: MVI-816 and pembrolizumab every 3 weeks (arm 3)
Number of subjects: 40
Study 35277461 — intervention group
Group type: EXPERIMENTAL
Intervention: MVI-816 every 2 weeks and pembrolizumab every 4 weeks (arm 4)
Number of subjects: 40
Study 35277461 — intervention group
Group type: EXPERIMENTAL
Intervention: MVI-816 and pembrolizumab (both arms)
Number of subjects: 40
Study 33939479 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone therapy
Number of subjects: 0
Study 33939479 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36199120 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving therapy (PST) plus BEACON smartphone application
Number of subjects: 0
Study 36199120 — intervention group
Group type: COMPARATOR
Intervention: Problem-solving therapy (PST) alone
Number of subjects: 0
Study 33888117 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional continuous glucose monitoring (CGM) sensor (iPro™2) worn for 7 days, followed by medical consultation and educational session
Number of subjects: 302
Study 33888117 — intervention group
Group type: EXPERIMENTAL
Intervention: Professional continuous glucose monitoring (CGM)
Number of subjects: 302
Study 32231850 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction of labor with oxytocin
Number of subjects: 50
Study 32231850 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous onset of labor
Number of subjects: 50
Study 35668643 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert instruction (EXP)
Number of subjects: 60
Study 35668643 — intervention group
Group type: COMPARATOR
Intervention: Video instruction (VID)
Number of subjects: 60
Study 35668643 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (EXP and VID)
Number of subjects: 60
Study 35318277 — intervention group
Group type: EXPERIMENTAL
Intervention: Olaparib beyond progression
Number of subjects: 200
Study 35318277 — intervention group
Group type: COMPARATOR
Intervention: Platinum-based chemotherapy
Number of subjects: 200
Study 32840311 — intervention group
Group type: EXPERIMENTAL
Intervention: Lower SHBG
Number of subjects: 573
Study 32840311 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher testosterone
Number of subjects: 573
Study 32840311 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher estrone, estradiol, and testosterone
Number of subjects: 573
Study 32840311 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher estradiol
Number of subjects: 573
Study 32840311 — intervention group
Group type: EXPERIMENTAL
Intervention: DHEAS
Number of subjects: 573
Study 32840311 — intervention group
Group type: EXPERIMENTAL
Intervention: Androstenedione
Number of subjects: 573
Study 34759989 — intervention group
Group type: EXPERIMENTAL
Intervention: Apple syrup (Malus domestica), administered three times a day along with antiemetic treatment and chemotherapy
Number of subjects: 34
Study 32086442 — intervention group
Group type: EXPERIMENTAL
Intervention: 10,000 voluntary contractions over 8 weeks
Number of subjects: 120
Study 32086442 — intervention group
Group type: COMPARATOR
Intervention: Usual care alone (Control Group)
Number of subjects: 120
Study 35044877 — intervention group
Group type: EXPERIMENTAL
Intervention: 1sIPV+2bOPV
Number of subjects: 968
Study 35044877 — intervention group
Group type: EXPERIMENTAL
Intervention: 2sIPV+1bOPV
Number of subjects: 968
Study 35044877 — intervention group
Group type: EXPERIMENTAL
Intervention: 2sIPV+1tOPV
Number of subjects: 968
Study 35044877 — intervention group
Group type: EXPERIMENTAL
Intervention: 1cIPV+2bOPV
Number of subjects: 968
Study 35044877 — intervention group
Group type: EXPERIMENTAL
Intervention: 2cIPV+1bOPV
Number of subjects: 968
Study 35044877 — intervention group
Group type: EXPERIMENTAL
Intervention: 2cIPV+1tOPV
Number of subjects: 968
Study 35044877 — intervention group
Group type: COMPARATOR
Intervention: All groups
Number of subjects: 968
Study 33144461 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative Pressure Wound Therapy (NPWT) using the PICO™ device
Number of subjects: 20
Study 34252252 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrolimus 0.1% ointment (T group)
Number of subjects: 38
Study 34252252 — intervention group
Group type: COMPARATOR
Intervention: Anti-inflammatory mouthwash (M group)
Number of subjects: 38
Study 33340751 — intervention group
Group type: EXPERIMENTAL
Intervention: Minimally invasive surgery (MIS)
Number of subjects: 1706
Study 33340751 — intervention group
Group type: COMPARATOR
Intervention: Laparotomy (Control)
Number of subjects: 1706
Study 32355959 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise combined with paired corticospinal‐motor neuronal stimulation (PCMS)
Number of subjects: 25
Study 32355959 — intervention group
Group type: EXPERIMENTAL
Intervention: PCMS without exercise
Number of subjects: 25
Study 32355959 — intervention group
Group type: COMPARATOR
Intervention: Exercise combined with sham‐PCMS
Number of subjects: 25
Study 32355959 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise with PCMS
Number of subjects: 25
Study 32355959 — intervention group
Group type: COMPARATOR
Intervention: Exercise with sham‐PCMS
Number of subjects: 25
Study 34264351 — intervention group
Group type: EXPERIMENTAL
Intervention: Deep learning-based algorithm
Number of subjects: 3073
Study 32205226 — intervention group
Group type: EXPERIMENTAL
Intervention: Lusutrombopag (3 mg) daily for 7 days before the invasive procedure
Number of subjects: 270
Study 32205226 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 270
Study 32205226 — intervention group
Group type: EXPERIMENTAL
Intervention: Lusutrombopag
Number of subjects: 270
Study 33685873 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (n = 104)
Number of subjects: 206
Study 33685873 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 102)
Number of subjects: 206
Study 32016644 — intervention group
Group type: EXPERIMENTAL
Intervention: 24 h severe energy restriction (ER)
Number of subjects: 16
Study 32016644 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised breakfast followed by ad libitum lunch and dinner
Number of subjects: 16
Study 32016644 — intervention group
Group type: EXPERIMENTAL
Intervention: Ad libitum energy intake on day 2
Number of subjects: 16
Study 32016644 — intervention group
Group type: EXPERIMENTAL
Intervention: Postprandial responses for CTX, P1NP, and PTH
Number of subjects: 16
Study 34636852 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger patients (yoCRC cohort)
Number of subjects: 2326
Study 34636852 — intervention group
Group type: COMPARATOR
Intervention: Older patients (50 years and older)
Number of subjects: 2326
Study 34636852 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients younger than age 35 years
Number of subjects: 2326
Study 34581270 — intervention group
Group type: EXPERIMENTAL
Intervention: Tamoxifen 300 mg/day
Number of subjects: 50
Study 34581270 — intervention group
Group type: COMPARATOR
Intervention: Standard care (amphotericin combined with fluconazole)
Number of subjects: 50
Study 33432367 — intervention group
Group type: EXPERIMENTAL
Intervention: Irradiated area cohort
Number of subjects: 100
Study 33432367 — intervention group
Group type: COMPARATOR
Intervention: De novo cohort
Number of subjects: 100
Study 32686744 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (cholecalciferol at 2000 IU) for 2 months
Number of subjects: 90
Study 35915923 — intervention group
Group type: EXPERIMENTAL
Intervention: Angiotensin-2
Number of subjects: 60
Study 35915923 — intervention group
Group type: COMPARATOR
Intervention: Noradrenaline
Number of subjects: 60
Study 34647315 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonoperative treatment
Number of subjects: 30
Study 34647315 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 30
Study 34647315 — intervention group
Group type: COMPARATOR
Intervention: Comparison between Nonoperative and Surgical groups
Number of subjects: 30
Study 32314828 — intervention group
Group type: EXPERIMENTAL
Intervention: sirolimus-based immunosuppression + CNIs (group B1; n = 44)
Number of subjects: 166
Study 32314828 — intervention group
Group type: EXPERIMENTAL
Intervention: sirolimus-based immunosuppression + CNIs (group B2; n = 34)
Number of subjects: 166
Study 32314828 — intervention group
Group type: COMPARATOR
Intervention: CNI-based immunosuppression (group A; n = 88)
Number of subjects: 166
Study 34334142 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care intervention by a pharmacist trained in motivational interviewing
Number of subjects: 316
Study 34334142 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmaceutical care intervention
Number of subjects: 316
Study 34334142 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 316
Study 33049287 — intervention group
Group type: EXPERIMENTAL
Intervention: Pragmatic care trials with 1:1 randomized allocation
Number of subjects: 1212
Study 33049287 — intervention group
Group type: EXPERIMENTAL
Intervention: Pragmatic care trials
Number of subjects: 1212
Study 35654683 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% atropine with orthokeratology (AOK)
Number of subjects: 96
Study 35654683 — intervention group
Group type: COMPARATOR
Intervention: orthokeratology (OK)
Number of subjects: 96
Study 33496775 — intervention group
Group type: EXPERIMENTAL
Intervention: In-clinic group intervention (n=468)
Number of subjects: 1407
Study 33496775 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone group intervention (n=466)
Number of subjects: 1407
Study 33496775 — intervention group
Group type: COMPARATOR
Intervention: In-clinic individual intervention (n=473)
Number of subjects: 1407
Study 35878584 — intervention group
Group type: EXPERIMENTAL
Intervention: Antidepressants treatment (specifics not provided)
Number of subjects: 25
Study 34052918 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronous contralateral axillary metastasis (CAM) diagnosis
Number of subjects: 588
Study 34052918 — intervention group
Group type: EXPERIMENTAL
Intervention: Diagnostic evaluations for CAM
Number of subjects: 588